Showing results (31-40 of 73) with videos related to
Sort By:
Pageof 8
Biochemical and Biophysical Research Communications|December 17, 2016
Ibandronate concomitantly blocks immobilization-induced bone and muscle atrophyRyuichi Watanabe, Nobuyuki Fujita, Satoshi Takeda, et al.Neuroscience Letters|September 19, 2012
Heptamethoxyflavone, a citrus flavonoid, enhances brain-derived neurotrophic factor production and neurogenesis in the hippocampus following cerebral global ischemia in miceSatoshi Okuyama, Naoko Shimada, Miki Kaji, et al.Reproductive Sciences (Thousand Oaks, Calif.)|February 13, 2020
Fetal Renal DNA Methylation and Developmental Programming of Stress-Induced Hypertension in Growth-Restricted Male MiceElizabeth DuPriest, Jessica Hebert, Mayu Morita, et al.Frontiers in Immunology|November 8, 2021
An Enriched Environment Alters DNA Repair and Inflammatory Responses After Radiation ExposureSae Sakama, Keisuke Kurusu, Mayu Morita, et al.Bone & Joint Research|May 13, 2026
Immune profiling in orthopaedic diseases using mass cytometry : a narrative review of applications and future directionsYosuke Susuki, Monica Thukkaram, Issei Shinohara, et al.Tissue Engineering. Part C, Methods|September 23, 2024
The Advantages and Shortcomings of Stem Cell Therapy for Enhanced Bone HealingSimon Kwoon-Ho Chow, Qi Gao, Alexa Pius, et al.Neurochemistry International|March 25, 2014
3,5,6,7,8,3',4'-Heptamethoxyflavone, a citrus flavonoid, on protection against memory impairment and neuronal cell death in a global cerebral ischemia mouse modelSatoshi Okuyama, Mayu Morita, Kazuhiro Miyoshi, et al.Plos One|November 2, 2016
Selective Estrogen Receptor Modulators Suppress Hif1α Protein Accumulation in Mouse OsteoclastsMayu Morita, Yuiko Sato, Ryotaro Iwasaki, et al.Biochemical and Biophysical Research Communications|January 22, 2016
Hif1α is required for osteoclast activation and bone loss in male osteoporosisToshimi Tando, Yuiko Sato, Kana Miyamoto, et al.Journal of Bone and Mineral Metabolism|December 24, 2017
Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditionsAkihito Oya, Eri Katsuyama, Mayu Morita, et al.Pageof 8